Webb, LV;
Barbarulo, A;
Huysentruyt, J;
Vanden Berghe, T;
Takahashi, N;
Ley, S;
Vandenabeele, P;
(2019)
Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB.
Immunity
, 50
(2)
348-361.e4.
10.1016/j.immuni.2019.01.004.
Preview |
Text
1-s2.0-S1074761319300044-main.pdf - Published Version Download (5MB) | Preview |
Abstract
NF-κB (nuclear factor κB) signaling is considered critical for single positive (SP) thymocyte development because loss of upstream activators of NF-κB, such as the IKK complex, arrests their development. We found that the compound ablation of RelA, cRel, and p50, required for canonical NF-κB transcription, had no impact upon thymocyte development. While IKK-deficient thymocytes were acutely sensitive to tumor necrosis factor (TNF)-induced cell death, Rel-deficient cells remained resistant, calling into question the importance of NF-κB as the IKK target required for thymocyte survival. Instead, we found that IKK controlled thymocyte survival by repressing cell-death-inducing activity of the serine/threonine kinase RIPK1. We observed that RIPK1 expression was induced during development of SP thymocytes and that IKK was required to prevent RIPK1-kinase-dependent death of SPs in vivo. Finally, we showed that IKK was required to protect Rel-deficient thymocytes from RIPK1-dependent cell death, underscoring the NF-κB-independent function of IKK during thymic development.
Type: | Article |
---|---|
Title: | Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.immuni.2019.01.004 |
Publisher version: | https://doi.org/10.1016/j.immuni.2019.01.004 |
Language: | English |
Additional information: | Crown Copyright © 2019 Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Keywords: | RIPK1, TNF, inhibitor of kappa-B kinase, nuclear factor kappa-B, thymocyte |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
URI: | https://discovery.ucl.ac.uk/id/eprint/10068994 |
Archive Staff Only
View Item |